Chapter 116. Immunization Principles and Vaccine Use (Part 9) pptx

12 280 0
Chapter 116. Immunization Principles and Vaccine Use (Part 9) pptx

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

Thông tin tài liệu

Chapter 116. Immunization Principles and Vaccine Use (Part 9) Table 116-3 Valid and Invalid Contraindications to Vaccination Vaccine Valid Contraindication a Invalid Contraindication Serious allergic reactions (e.g., anaphyla xis) to a previous vaccine dose or a vaccine component Mild acute illness with or without fever All vaccines in general Precaution: Moderate Mild to moderate local or severe concurrent illness with or without fever reactions; low- grade or moderate fever after a previous dose Lack of previous physical examination in a well-appearing person Current antimicrobial therapy (except certain live bacterial vaccines) Convalescent phase of illness Premature birth (except hepatitis B in some circumstances) Recent expos ure to infectious diseases History of penicillin allergy, other nonvaccine allergies; relatives with allergies; receiving desensitization treatment Severe allergic reaction to a previous dose or a vaccine component Temperature of <40.5°C; fuss iness; mild drowsiness after a prior dose of DTP or DTaP Encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures) within 7 days of a previous dose of DTP or DTaP Family history of seizures, sudden infant death syndrome, or advers e event after DTP or DTaP DTaP b Progressive neurologic disorder, including infantile spasms, Stable neurologic conditions (e.g., cerebral palsy, well- controlled uncontrolled epilepsy, progressive encephalopathy: defer DTaP until neurologic status is clarified and stabilized convulsions, developmental delay) Precaution: Fever of ≥40.5°C at ≤48 h after a previous dose of DTP or DTaP Collapse or shock- like state (i.e., hypotonic hyporesponsive episode ≤48 h after a previous dose of DTP or DTaP) Seizure ≤3 days after a previous dose of DTP or DTaPPersistent, inconsolable crying lasting ≥3 h/≤48 h after a previous dose of DTP or DTaP Moderate or severe acute illness with or without fever Severe allergic reaction after a previous dose or to a vaccine component Precaution: Guillain- Barré syndrome ≤6 weeks after a previous dose of tetanus toxoid– containing vaccine DT, Td Moderate or severe acute illness with or without fever Severe allergic reaction to a previous dose or a vaccine component IPV Precautions: Pregnancy; moderate or severe acute illness with or without fever Severe allergic reaction to a previous dose or a vaccine component Positive tuberculin skin test; simultaneous TB skin testing Pregnancy Breast-feeding MMR Known severe immunodeficiency (e.g., hematologic and solid tumors, congenital immunodeficiency, long- term immunosuppressive Pregnancy of recipient's mother or other close or household contact; recipient is childbearing- age female or immunodeficient family member or household therapy, or severely symptomatic HIV infection) contact; asymptomatic or mildly symptomatic HIV infection; allergy to eggs Precautions: Recent ( ≤11 months) receipt of antibody- containing blood products (specific interval depends on product ); history of thrombocytopenia and thrombocytopenic purpura; moderate or severe acute illness with or without fever Severe allergic reaction to a previous dose or a vaccine component Age <6 weeks Hib Precaution: Moderate or severe acute illness with or without fever Severe allergic reaction to a previous dose or a vaccine component Pregnancy; autoimmune disease (e.g., systemic lupus erythematosus or rheumatoid arthritis) Hepatitis B Precautions: Infant weighing <2000 g; moderate or severe acute illness with or without fever Severe allergic reaction to a previous dose or a vaccine component Hepatitis A Precaution: Pregnancy; moderate or severe acute illness with or without fever Severe allergic reaction to a previous do se or a vaccine component Pregnancy of recipient's mother or another close or household contact Substantial suppression of cellular immunity Immunodeficient family member or household contact; asymptomatic or mildly symptomatic HIV infection Pregnancy Varicella Precaution: Recent ( ≤11 months) receipt of antibody- containing blood products (specific interval depends on product) Pneumococcal Severe allergic reaction to a previous dose or a vaccine component Precaution: Moderate or sev ere acute illness with or without fever Severe allergic reaction to a previous dose or a vaccine component, including egg protein Nonsevere (e.g., contact) allergy to latex or thimerosal; concurrent administration of warfarin or aminophylline Influenza Precaution: Moderate or severe acute illness with or without fever Severe allergic reaction to a previous dose or a vaccine component Pneumococcal polysaccharide vaccines Precaution: Moderate [...]... diphtheria and tetanus toxoids and whole-cell pertussis vaccine; DTaP, diphtheria and tetanus toxoids and acellular pertussis vaccine; DT, diphtheria and tetanus toxoids; Td, tetanus and reduced-dose diphtheria toxoids, adsorbed; IPV, inactivated polio vaccine; MMR, measles, mumps, and rubella vaccine; Hib, Haemophilus influenzae type b vaccine Source: General 51(RR02):1, 2002 Recommendations on Immunization. .. precautions should be reviewed carefully Benefits and risks of administering a specific vaccine to a person under these circumstances should be considered If the risk from the vaccine is believed to outweigh the benefit, the vaccine should not be administered If the benefit of vaccination is believed to outweigh the risk, the vaccine should be administered b Whether and when to administer DTaP to children with . Chapter 116. Immunization Principles and Vaccine Use (Part 9) Table 116- 3 Valid and Invalid Contraindications to Vaccination Vaccine Valid Contraindication a . diphtheria and tetanus toxoids and whole- cell pertussis vaccine; DTaP, diphtheria and tetanus toxoids and acellular pertussis vaccine; DT, diphtheria and tetanus toxoids; Td, tetanus and reduced-dose. adsorbed; IPV, inactivated polio vaccine; MMR, measles, mumps, and rubella vaccine; Hib, Haemophilus influenzae type b vaccine. Source: General Recommendations on Immunization. MMWR 51(RR02):1,

Ngày đăng: 07/07/2014, 04:20

Từ khóa liên quan

Tài liệu cùng người dùng

Tài liệu liên quan